Division of Urology, Children's Hospital of Philadelphia, 3401 Civic Center Blvd, Philadelphia, PA 19104, USA; Division of Urology, Hospital of the University of Pennsylvania, Perelman Center for Advanced Care, 3400 Civic Center Blvd, 3rd Floor West Pavilion, Philadelphia, PA 19104, USA.
Division of Urology, Children's Hospital of Philadelphia, 3401 Civic Center Blvd, Philadelphia, PA 19104, USA.
J Pediatr Urol. 2022 Aug;18(4):517.e1-517.e5. doi: 10.1016/j.jpurol.2022.04.005. Epub 2022 Apr 13.
With the advent of robot-assisted laparoscopic ureteral reimplantation (RALUR) for primary vesicoureteral reflux (VUR), understanding and minimizing its complications continues to be critical. Incidence of de novo hydronephrosis after RALUR could be indicative of an outcome that needs further study or could be a benign transient finding.
In the present study, we hypothesized that the incidence of de novo hydronephrosis after RALUR is low and resolves spontaneously.
An IRB-approved prospective single-institutional registry was utilized to identify all patients undergoing RALUR via an extravesical approach from 2012 to 2020. Patients with primary VUR and minimal (Grade I SFU) or no hydronephrosis prior to surgery were included. Patients who had other associated pathology or underwent concomitant procedures were excluded. Preoperative characteristics including VUR and hydronephrosis grades as well as post-operative clinical details and hydronephrosis grades were aggregated and analyzed.
86/172 (50%) patients (133 ureters), with median reflux grade of 3 (IQR: G2, G3) met the inclusion criteria. Patients underwent RALUR at a median age of 5.7 years (IQR: 3.4, 8.7) with median 36.2 months (IQR: 19.6, 63.6) follow-up. Renal ultrasound at 4-6 weeks post-op showed de novo hydronephrosis in 18 (13.5%) ureters; the complete resolution was seen in 13 ureters (72%) at a median of 4.5 months from surgery. Among the 5 with non-resolved hydronephrosis (SFU G2:4, G3:1), 2 patients (3 ureters) underwent subsequent interventions.
The present study evaluating the natural history of de novo hydronephrosis after RALUR-EV performed for primary VUR, is to our knowledge the largest cohort of patients undergoing RALUR that this has been studied in. In our cohort, the incidence of de novo hydronephrosis after RALUR was 13.5%, similar to rates reported in two OUR cohorts, and significantly lower than reported incidence rates of 22-26% in several OUR cohorts, and 30% in a RALUR cohort. In the present cohort, hydronephrosis resolved spontaneously in more than 72% of cases. The median time from surgery until resolution of hydronephrosis was 4.5 (1.6, 10.5) months, which is shorter in comparison to the average time to resolution of 7.6 months, reported by Kim et al. in an earlier study.
De novo hydronephrosis after RALUR can be followed with serial renal ultrasounds. The majority of de novo hydronephrosis post-RALUR is transient and resolves spontaneously within a year of surgery with a very low re-intervention rate.
随着机器人辅助腹腔镜输尿管再植术(RALUR)治疗原发性膀胱输尿管反流(VUR)的出现,了解和最小化其并发症仍然至关重要。RALUR 后新出现的肾积水的发生率可能表明需要进一步研究的结果,也可能是良性的暂时发现。
在本研究中,我们假设 RALUR 后新出现肾积水的发生率较低且可自发缓解。
利用经皮入路的机器人辅助腹腔镜输尿管再植术(RALUR),利用机构审查委员会批准的前瞻性单机构注册中心,对 2012 年至 2020 年期间接受 RALUR 的所有患者进行了识别。纳入具有原发性 VUR 和最小(SFU 分级 I)或无术前肾积水的患者。排除有其他相关病变或同时进行其他手术的患者。聚合和分析了术前特征,包括反流分级和肾积水分级,以及术后临床资料和肾积水分级。
86/172(50%)名患者(133 侧输尿管)符合纳入标准,反流分级中位数为 3(IQR:G2,G3)。患者的 RALUR 中位年龄为 5.7 岁(IQR:3.4,8.7),中位随访时间为 36.2 个月(IQR:19.6,63.6)。术后 4-6 周的肾脏超声显示 18 侧(13.5%)输尿管出现新发性肾积水;13 侧(72%)在术后 4.5 个月完全缓解。在未缓解的 5 例肾积水(SFU G2:4 例,G3:1 例)中,2 例(3 侧)患者随后进行了干预。
本研究评估了原发性 VUR 行 RALUR-EV 后 RALUR 后新发性肾积水的自然史,据我们所知,这是目前研究中 RALUR 患者数量最多的队列。在我们的队列中,RALUR 后新发性肾积水的发生率为 13.5%,与两个 OUR 队列报告的发生率相似,明显低于几个 OUR 队列报告的 22-26%的发生率,以及 RALUR 队列报告的 30%的发生率。在本队列中,超过 72%的病例肾积水可自发缓解。从手术到肾积水缓解的中位时间为 4.5(1.6,10.5)个月,与 Kim 等人之前的研究报告的 7.6 个月平均缓解时间相比更短。
RALUR 后新出现的肾积水可以通过连续的肾脏超声检查来监测。大多数 RALUR 后新出现的肾积水是暂时的,在手术后 1 年内可自发缓解,再干预率很低。